Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans

Highlights Broad variation in neutralizing antibodies in SARS-CoV-2-convalescent individuals. ∼3% individuals showed a potent antibody response with SARS-CoV-1 cross-reactivity. Older age, symptomatic and severe disease predict higher SARS-CoV-2 neutralization. Serum and IgG neutralization half-lives were 14.7 and 31.4 weeks respectively. Summary Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the […]

Read More